Skip to main content

Day: April 20, 2021

Forløb af ordinær generalforsamling i Kapitalforeningen BLS Invest

Kapitalforeningen BLS Invest har i dag afholdt ordinær generalforsamling i henhold til tidligere offentliggjort dagsorden. Ledelsens beretning og årsrapporten for 2020 herunder de tidligere udbetalte foreløbige udlodninger samt bestyrelsens honorar for 2020 blev godkendt af generalforsamlingen. Til bestyrelsen genvalgtes Chris Bigler, Søren B. Andersson, Anne Christina Skjønnemand og Mikael Skov, ligesom EY Godkendt Revisionspartnerselskab genvalgtes som revisor for foreningen. Bestyrelsen konstituerede sig efterfølgende med Chris Bigler som formand. Eventuel henvendelse vedrørende denne meddelelse kan rettes til bestyrelsens formand, Chris Bigler tlf. 29 74 06 55 eller CEO Martin Udbye Madsen, tlf. 44 55 86 45. Med venlig hilsenKapitalforeningen BLS Invest Chris BiglerFormand for bestyrelsen Vedhæftet filFB_BLS_Invest_forloeb_GF_20...

Continue reading

CORRECTING AND REPLACING — Agile Therapeutics

PRINCETON, N.J., April 20, 2021 (GLOBE NEWSWIRE) — In a release issued earlier today by Agile Therapeutics, Inc. (Nasdaq: AGRX), please note the headline should read “Agile Therapeutics to Report First Quarter 2021 Financial Results and Provide Business Update on Tuesday, May 4, 2021” instead of “Agile Therapeutics to Report First Quarter 2021 Financial Results and Provide Business Update on Tuesday, May 4, 2020”. The corrected release follows: Agile Therapeutics to Report First Quarter 2021 Financial Results and Provide Business Update on Tuesday, May 4, 2021 Live Conference Call and Webcast at 4:30 p.m. EDT Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced it will report first quarter 2021 financial results after the market close on Tuesday, May 4, 2021 as follows:Date Tuesday,...

Continue reading

CNL Strategic Capital Announces Year-End 2020 Operating Results

Orlando, Fla., April 20, 2021 (GLOBE NEWSWIRE) — CNL Strategic Capital, LLC (“CNL Strategic Capital,” the “Company” or “we”) seeks to provide current income and long-term appreciation to its investors by acquiring controlling equity stakes in combination with loan positions in privately owned middle-market businesses. The Company announced its operating results for the year ended Dec. 31, 2020, CNL Strategic Capital’s third year of operation. 2020 HighlightsCNL Strategic Capital received approximately $125.3 million from the sale of approximately 4.4 million shares during the year ended Dec. 31, 2020, bringing total gross proceeds to $291 million. As of Dec. 31, 2020, CNL Strategic Capital had approximately $314.1 million in total assets, compared with approximately $175.5 million as of Dec. 31, 2019. CNL Strategic Capital closed...

Continue reading

Beam Therapeutics Publishes Data Highlighting Ability to Rationally Design Base Editors for Precise Editing

Data Published in The CRISPR Journal Describe Inlaid Base Editors (IBEs) that Enhance Editing Efficiency and Capability, an Advancement of the Company’s Pioneering Work in Developing Base Editors Data Demonstrates Utility of IBEs in BEAM-102, Enabling Conversion of Sickle Cell Hemoglobin Allele to the Naturally Occurring, Benign HbG-Makassar Variant in Patient-derived Hematopoietic Stem Cells CAMBRIDGE, Mass., April 20, 2021 (GLOBE NEWSWIRE) — Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the publication of work describing inlaid base editors (IBEs) in The CRISPR Journal. IBEs are architectural variants of base editors that have attributes of enhanced specificity and altered activity windows relative to foundational base editors. The work...

Continue reading

ScottsMiracle-Gro Announces Timing of Second Quarter 2021 Financial Results and Conference Call

MARYSVILLE, Ohio, April 20, 2021 (GLOBE NEWSWIRE) — The Scotts Miracle-Gro Company (NYSE SMG), one of the world’s largest marketers of branded consumer lawn and garden products, will release its second quarter financial results on Wednesday, May 5, 2021, prior to the opening of the U.S. financial markets. The Company will host a conference call to discuss those results at 9:00 a.m. ET. To participate in the conference call, please call 800-289-0438 (Conference Code: 5691876). A replay of the call can be heard by calling 888-203-1112. The replay will be available for 15 days. A live webcast of the call and the press release will be available on the Company’s investor relations website at http://investor.scotts.com. An archive of the press release and any accompanying information will remain available for at least a 12-month period. About...

Continue reading

North America Feeding Tubes Market to Reach USD 1,014.9 Million by 2028; Rapid Shift towards Enteral Feeding to Boost Growth, says Fortune Business Insights™

Pune, India, April 20, 2021 (GLOBE NEWSWIRE) — The North America feeding tubes market is set to gain momentum from the increasing shift of people towards enteral feeding from parenteral feeding because of its several benefits. It promotes the local immune function of the gut and eliminates villous atrophy. Hence, manufacturers nowadays are developing novel products to cater to the high demand. In June 2020, for instance, Applied Medical Technology, Inc. (AMT) introduced AMT ONE Source™, its latest mobile app to offer easy and quick access to the company’s educational materials. This information is given by Fortune Business Insights™ in a new report, titled, “North America Feeding Tubes Market, 2021-2028.” As per the report, the North America feeding tubes market size is expected to grow from USD 516.1 million in 2020 to USD 1,014.9...

Continue reading

View Systems, Inc.’s (VSYM) Sannabis Announces New Product to Supply the Food and Beverage Industry with Cannabis Flavorings Full of Terpenes and Flavonoids to Enhance a Products Essence and Therapeutic Value

Sannabis recently announced approvals by an Inspector from Colombia’s Ministry of Agriculture of their Seed Bank Facilities in anticipation of the Issuance of a coveted Cannabis Seed Use License. Cali, Colombia, April 20, 2021 (GLOBE NEWSWIRE) — View Systems, Inc.’s (OTC:VSYM), Sannabis S.A.S. (the “Company”), a Colombian cannabis company, announces the development of a new product to supply the food and beverage industry with Cannabis flavorings. For several years Sannabis has been producing an essential oil with a mystical therapeutic essence that captivated users with the pure aroma and flavor of the botanical components of Cannabis. Sannabis redeveloped its essential oil into a Non-THC raw material that can be used by food and drink companies to flavor potentially hundreds of different products. Recently PepsiCo announced their...

Continue reading

Healthcare Asset Management Market Size 2021 | To Exhibit an Excellent CAGR of 28.9% and Hit USD 84,483.03 Million by 2027

Pune, India, April 20, 2021 (GLOBE NEWSWIRE) — The global “Healthcare Asset Management” Market is predicted to reach USD 84,483.03 million by 2027, exhibiting a CAGR of 28.9% during the forecast period. The increasing technological advancement has led to high demand for asset management solutions in medical facilities, which, in turn, will accelerate the healthcare asset management market growth. Moreover, the introduction of wireless connectivity in asset management solutions will contribute positively to this growth during the forecast period, mentioned in a report, titled “Healthcare Asset Management Market Size, Share & Industry Analysis, By Product (Radiofrequency Identification (RFID), Real-time Location Systems (RTLS), Others), By Application (Staff Management, Equipment Tracking, Patient Tracking, Supply Chain Management),...

Continue reading

Injectable Drug Delivery Market to Rise at a CAGR of 12.9% by 2027 Owing to Increasing Prevalence of Chronic Diseases: Fortune Business Insights™

Pune India, April 20, 2021 (GLOBE NEWSWIRE) — The global injectable drug delivery market is anticipated to rise at a CAGR of 12.9% to reach USD 1,251.28 billion by the end of 2027 owing to the increasing prevalence of various diseases and the need for easy drug delivery to various target sites. Injectable drug delivery helps to provide effective drug delivery experience with speedy delivery. It is also considered as one of the most efficient routes of administration, thus ensuring improved patient experience. As per a report by Fortune Business Insights, titled, “Injectable Drug Delivery Market Size, Share & COVID-19 Impact Analysis, By Device Type (Conventional Injectable, Pre-filled syringes, Auto- injectors, Pen Injectors, and Wearable), By Product Type (Freeze-dried Products, Injectable Sterile Products), By End User (Hospitals,...

Continue reading

Yacht Charter Market to Grow into USD 144.21 Billion Market at CAGR of 6.7% during 2021-2027 | Facility Expansion by Fraser Yachts and Worldwide Boat to Create Promising Growth Opportunities

Pune, India, April 20, 2021 (GLOBE NEWSWIRE) — According to the report, Yacht Charter Market size is projected to reach USD 10.82 Billion value by 2027, exhibiting a CAGR of 6.6%. The global yacht charter market size is expected to reach USD 10.82 billion by 2027 backed by the growing number of HNWI and the increasing number of intermediaries that is likely to boost the demand for yacht charter services globally. What does the Report Provide? The market report provides in-depth analysis of several factors such as the key drivers and restraints that will impact growth. Additionally, the report provides insights into the regional analysis that covers different regions, which are contributing to the growth of the market. It includes the competitive landscape that involves the leading companies and the adoption of strategies by them...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.